Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas1

[1]  Jennie W. Taylor,et al.  Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT , 2017, Acta Neuropathologica.

[2]  Jason C. Crane,et al.  Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen , 2016, Neuro-oncology.

[3]  Susan M. Chang,et al.  Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma , 2017, Journal of Neuro-Oncology.

[4]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[5]  Susan M. Chang,et al.  Magnetic resonance analysis of malignant transformation in recurrent glioma , 2016, Neuro-oncology.

[6]  M. Khasraw,et al.  Evolving management of low grade glioma: No consensus amongst treating clinicians , 2016, Journal of Clinical Neuroscience.

[7]  S. Taillibert,et al.  Current Management of Adult Diffuse Infiltrative Low Grade Gliomas , 2016, Current Neurology and Neuroscience Reports.

[8]  J. Sarkaria,et al.  Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma? , 2015, Seminars in radiation oncology.

[9]  Steven J. M. Jones,et al.  Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. , 2015, The New England journal of medicine.

[10]  Alexander R. Pico,et al.  Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. , 2015, The New England journal of medicine.

[11]  Susan M. Chang,et al.  Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab , 2014, Journal of Neuro-Oncology.

[12]  A. Lagares,et al.  A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas , 2014, American Journal of Neuroradiology.

[13]  Soonmee Cha,et al.  Comparison of DSC‐MRI post‐processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM , 2013, Journal of magnetic resonance imaging : JMRI.

[14]  Jason C. Crane,et al.  SIVIC: Open-Source, Standards-Based Software for DICOM MR Spectroscopy Workflows , 2013, Int. J. Biomed. Imaging.

[15]  Susan M. Chang,et al.  Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging. , 2013, Neuro-oncology.

[16]  Christophe Lenglet,et al.  A Framework for Linear and Non-Linear Registration of Diffusion-Weighted MRIs Using Angular Interpolation , 2013, Front. Neurosci..

[17]  D. Yousem,et al.  ADC values and prognosis of malignant astrocytomas: does lower ADC predict a worse prognosis independent of grade of tumor?--a meta-analysis. , 2013, AJR. American journal of roentgenology.

[18]  A. Bozzao,et al.  Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status , 2013, European Radiology.

[19]  Mitchel S Berger,et al.  Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. , 2012, Neuro-oncology.

[20]  Susan M. Chang,et al.  Spatial characteristics of newly diagnosed grade 3 glioma assessed by magnetic resonance metabolic and diffusion tensor imaging. , 2012, Translational oncology.

[21]  Mitchel S. Berger,et al.  Magnetic Resonance of 2-Hydroxyglutarate in IDH1-Mutated Low-Grade Gliomas , 2012, Science Translational Medicine.

[22]  Inas S. Khayal,et al.  MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas. , 2011, Neuro-oncology.

[23]  Susan M. Chang,et al.  Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme. , 2011, Neuro-oncology.

[24]  Mei-Yin Polley,et al.  Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma. , 2011, Neuro-oncology.

[25]  D. Paraskevopoulos,et al.  Comparative study of application accuracy of two frameless neuronavigation systems: experimental error assessment quantifying registration methods and clinically influencing factors , 2011, Neurosurgical Review.

[26]  Albert P. Chen,et al.  Implementation of 3 T Lactate-Edited 3D 1H MR Spectroscopic Imaging with Flyback Echo-Planar Readout for Gliomas Patients , 2010, Annals of Biomedical Engineering.

[27]  Inas S. Khayal,et al.  Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging. , 2009, Translational oncology.

[28]  Mitchel S Berger,et al.  Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. , 2007, Journal of neurosurgery.

[29]  Esin Ozturk-Isik,et al.  Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T. , 2006, Magnetic resonance imaging.

[30]  John M Pauly,et al.  Design of flyback echo‐planar readout gradients for magnetic resonance spectroscopic imaging , 2005, Magnetic resonance in medicine.

[31]  Susan M. Chang,et al.  Dynamic susceptibility contrast perfusion imaging of radiation effects in normal‐appearing brain tissue: Changes in the first‐pass and recirculation phases , 2005, Journal of magnetic resonance imaging : JMRI.

[32]  M. Berger,et al.  Coregistration Accuracy and Detection of Brain Shift Using Intraoperative Sononavigation during Resection of Hemispheric Tumors , 2003, Neurosurgery.

[33]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[34]  D. Vigneron,et al.  An automated technique for the quantitative assessment of 3D‐MRSI data from patients with glioma , 2001, Journal of magnetic resonance imaging : JMRI.

[35]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.

[36]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .